重度哮喘最低临床疾病活动度与缓解的改良德尔菲共识定义
该共识由呼吸领域医疗专业人员组成的指导委员会制定,采用系统文献综述与改良德尔菲法,经指导委员会两轮审阅及更广泛医疗人员一轮审阅后形成共识声明。基于共识声明起草并最终确定重度哮喘「最低临床疾病活动度」与「缓解」的定义,涵盖哮喘急性发作、激素使用、肺功能与生活质量等标准。作者指出这些定义是改善重度哮喘疾病管理的起点,仍需在真实世界环境中验证。
要点
- 共识提出重度哮喘「缓解」与「最低临床疾病活动度」两套定义,后者标准相对宽松。
- 定义涵盖哮喘急性发作、激素使用、肺功能和生活质量四类标准。
- 定义尚属起点,需在真实世界环境中进一步验证后用于临床管理。
核心结论
- 共识给出了重度哮喘「最低临床疾病活动度」与「缓解」的定义,作为改善疾病管理的起点,并需在真实世界环境中验证。
研究设计与样本
- 由呼吸领域医疗专业人员组成指导委员会,采用系统文献综述与改良德尔菲共识法。
- 系统文献综述的输出用于起草共识声明,经指导委员会两轮审阅和更广泛医疗人员一轮审阅,定义在指导委员会会议上最终确定。
主要发现
- 生物制剂改善重度哮喘患者结局并引发对「缓解」的讨论,但缓解描述不一,亟需标准化定义作为患者治疗目标。
- 缓解标准严格以追求最佳结局,但并非所有患者都能达到缓解,取决于疾病严重程度与病程,因此也应考虑较低标准如最低临床疾病活动度。
关键数值与推荐
- 定义包含哮喘急性发作、激素使用、肺功能和生活质量方面的标准。
临床怎么用
- 可将共识定义作为重度哮喘管理目标的参考框架,用于区分追求缓解与最低临床疾病活动度的患者。
- 在真实世界验证前,定义应作为起点而非最终标准应用于临床。
局限性
- 定义尚需在真实世界环境中验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
J Allergy Clin Immunol Pract. 2026 Oct;14(10):2262-2275.e3. doi: 10.1016/j.jaip.2026.07.011. Epub 2026 Jul 16. ABSTRACT The introduction of biologics in the treatment of severe asthma has led to improved patient outcomes and increased discussions around remission. Due to varying descriptions of remission, there is a clear need for a standardized definition of remission as a target for patients. Remission has stringent criteria to achieve the best possible outcomes for patients; however, not all patients achieve remission dependent on the disease severity and duration. Therefore, less stringent criteria should also be considered, such as a patient's state of minimal clinical disease activity. To explore these definitions, a Steering Committee of respiratory healthcare professionals employed a systematic literature review and modified Delphi consensus. Outputs of the systematic literature review were used to draft consensus statements that underwent two rounds of review with the Steering Committee and one round of review with a wider group of healthcare professionals. Initial definitions of minimal clinical disease activity and remission were drafted based on the consensus statements and finalized in a Steering Committee meeting. The definitions include criteria for asthma exacerbations, steroid use, lung function, and quality of life. These definitions serve as a starting point for improving disease management in patients with severe asthma and should be validated in real-world settings. PMID: 42463041 | DOI: 10.1016/j.jaip.2026.07.011
引用
- 指南共识 · 哮喘:Defining Minimal Clinical Disease Activity and Remission in Severe Asthma: A Modified Delphi Consensus
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。